tiprankstipranks
Fresh Tracks Therapeutics (FRTX)
OTHER OTC:FRTX
US Market

Fresh Tracks Therapeutics (FRTX) Income Statement

Compare
507 Followers

Fresh Tracks Therapeutics Income Statement

Last quarter (Q4 2023), Fresh Tracks Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Fresh Tracks Therapeutics's net income was $-1.24M. See Fresh Tracks Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.01M$ 6.94M$ 404.00K$ 1.82M$ 7.92M
Gross Profit
$ 8.01M$ -7.10M$ -27.83M$ -9.39M$ -12.30M
Operating Expenses
$ 14.37M$ 28.48M$ 40.65M$ 22.80M$ 32.38M
Depreciation and Amortization
$ 41.00K$ 30.00K$ 22.00K$ 10.00K$ 28.00K
EBITDA
$ -5.65M$ -21.06M$ -39.38M$ -20.90M$ -24.47M
Operating Income
$ -6.36M$ -21.53M$ -40.24M$ -20.98M$ -24.47M
Other Income/Expenses
$ 666.00K$ 432.00K$ 770.00K$ 63.00K$ 591.00K
Pretax Income
$ -5.69M$ -21.10M$ -39.47M$ -20.91M$ -23.88M
Net Income
$ -5.69M$ -20.66M$ -39.52M$ -20.90M$ -25.95M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.96$ -7.36$ -22.14$ -38.37$ -386.21
Diluted EPS
$ -0.96$ -7.36$ -22.14$ -38.37$ -386.21
Weighted Average Shares Outstanding
5.91M 2.81M 1.78M 544.76K 67.18K
Weighted Average Shares Outstanding (Diluted)
5.91M 2.81M 1.78M 544.76K 67.18K
Currency in USD

Fresh Tracks Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis